S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
Log in
NASDAQ:SURF

Surface Oncology News Headlines

$8.47
-0.55 (-6.10 %)
(As of 03/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$8.39
Now: $8.47
$9.23
50-Day Range
$8.44
MA: $11.07
$13.82
52-Week Range
$1.38
Now: $8.47
$14.40
Volume1.46 million shs
Average Volume1.29 million shs
Market Capitalization$344.53 million
P/E RatioN/A
Dividend YieldN/A
Beta2.09

Headlines

Surface Oncology (NASDAQ SURF) News Headlines Today

Source:
SourceHeadline
Surface Oncology (NASDAQ:SURF) Upgraded by Zacks Investment Research to "Buy"Surface Oncology (NASDAQ:SURF) Upgraded by Zacks Investment Research to "Buy"
marketbeat.com - February 25 at 5:13 AM
Cathie Wood’s ARK Invest Buys and Sells 3/2Cathie Wood’s ARK Invest Buys and Sells 3/2
msn.com - March 2 at 9:51 PM
Surface Oncology, Inc. (SURF) to Report Q4 Results: Wall Street Expects Earnings GrowthSurface Oncology, Inc. (SURF) to Report Q4 Results: Wall Street Expects Earnings Growth
finance.yahoo.com - March 2 at 4:51 PM
Thinking about buying stock in Cerecor, Surface Oncology, SINTX Technologies, Clearpoint Neuro, or Senseonics Holdings?Thinking about buying stock in Cerecor, Surface Oncology, SINTX Technologies, Clearpoint Neuro, or Senseonics Holdings?
prnewswire.com - March 2 at 11:51 AM
Surface Oncology (NASDAQ:SURF) Shares Gap Up to $9.02Surface Oncology (NASDAQ:SURF) Shares Gap Up to $9.02
americanbankingnews.com - March 2 at 10:54 AM
Surface Oncology (NASDAQ:SURF) Trading 6.4% Higher Surface Oncology (NASDAQ:SURF) Trading 6.4% Higher
americanbankingnews.com - March 1 at 8:38 PM
Surface Oncology (NASDAQ:SURF)  Shares Down 7.2% Surface Oncology (NASDAQ:SURF) Shares Down 7.2%
americanbankingnews.com - February 25 at 8:58 PM
Surface Oncology to Participate in Upcoming March Investor ConferencesSurface Oncology to Participate in Upcoming March Investor Conferences
finance.yahoo.com - February 24 at 10:50 AM
What Type Of Shareholders Make Up Surface Oncology, Inc.s (NASDAQ:SURF) Share Registry?What Type Of Shareholders Make Up Surface Oncology, Inc.'s (NASDAQ:SURF) Share Registry?
finance.yahoo.com - February 22 at 12:51 PM
Insider Selling: Surface Oncology, Inc. (NASDAQ:SURF) Insider Sells 1,000 Shares of StockInsider Selling: Surface Oncology, Inc. (NASDAQ:SURF) Insider Sells 1,000 Shares of Stock
americanbankingnews.com - February 18 at 9:30 PM
Surface Oncology (NASDAQ:SURF) Stock Price Down 9.8%Surface Oncology (NASDAQ:SURF) Stock Price Down 9.8%
americanbankingnews.com - February 18 at 8:54 PM
Surface Oncology to Appoint Robert Ross, M.D., as President and Chief Executive OfficerSurface Oncology to Appoint Robert Ross, M.D., as President and Chief Executive Officer
finance.yahoo.com - February 11 at 7:23 AM
Surface Oncology (NASDAQ:SURF) & Mymetics (OTCMKTS:MYMX) Critical ContrastSurface Oncology (NASDAQ:SURF) & Mymetics (OTCMKTS:MYMX) Critical Contrast
americanbankingnews.com - February 10 at 12:24 AM
Insider Selling: Surface Oncology, Inc. (NASDAQ:SURF) CEO Sells 2,500 Shares of StockInsider Selling: Surface Oncology, Inc. (NASDAQ:SURF) CEO Sells 2,500 Shares of Stock
americanbankingnews.com - February 9 at 10:12 PM
Surface Oncology, Inc. (NASDAQ:SURF) Insider Sells $18,675.00 in StockSurface Oncology, Inc. (NASDAQ:SURF) Insider Sells $18,675.00 in Stock
americanbankingnews.com - February 9 at 9:40 PM
Surface Oncology (NASDAQ:SURF) Trading Up 12.4%Surface Oncology (NASDAQ:SURF) Trading Up 12.4%
americanbankingnews.com - February 8 at 7:32 PM
3 Reasons This Hot Stock May Not Survive 20213 Reasons This Hot Stock May Not Survive 2021
msn.com - January 24 at 2:20 PM
Surface Oncology Is Set for Further Gains - How to Buy ItSurface Oncology Is Set for Further Gains - How to Buy It
finance.yahoo.com - January 19 at 7:21 PM
Are Options Traders Betting on a Big Move in Surface Oncology (SURF) Stock?Are Options Traders Betting on a Big Move in Surface Oncology (SURF) Stock?
finance.yahoo.com - January 13 at 1:25 PM
bluebird bio to Separate Oncology Business into Independent Companybluebird bio to Separate Oncology Business into Independent Company
businesswire.com - January 11 at 7:01 AM
Surface Oncology to Participate in H.C. Wainwright Bioconnect 2021 ConferenceSurface Oncology to Participate in H.C. Wainwright Bioconnect 2021 Conference
finance.yahoo.com - January 11 at 7:01 AM
If You Had Bought Surface Oncology (NASDAQ:SURF) Stock A Year Ago, You Could Pocket A 498% Gain TodayIf You Had Bought Surface Oncology (NASDAQ:SURF) Stock A Year Ago, You Could Pocket A 498% Gain Today
finance.yahoo.com - December 22 at 1:05 PM
Earnings Estimates Moving Higher for Surface Oncology, Inc. (SURF): Time to Buy?Earnings Estimates Moving Higher for Surface Oncology, Inc. (SURF): Time to Buy?
finance.yahoo.com - December 22 at 1:05 PM
Surface Oncology Announces Exclusive License Agreement with GSK for Novel Immunotherapy ProgramSurface Oncology Announces Exclusive License Agreement with GSK for Novel Immunotherapy Program
finance.yahoo.com - December 17 at 8:09 AM
Where Do Hedge Funds Stand On Surface Oncology, Inc. (SURF)?Where Do Hedge Funds Stand On Surface Oncology, Inc. (SURF)?
finance.yahoo.com - December 14 at 7:53 AM
Surface Oncology: Early Stage Cancer-Specific Company With Novel AssetsSurface Oncology: Early Stage Cancer-Specific Company With Novel Assets
seekingalpha.com - December 9 at 4:09 PM
Surface Oncology to Participate in the 3rd Annual Evercore ISI HealthCONx ConferenceSurface Oncology to Participate in the 3rd Annual Evercore ISI HealthCONx Conference
finance.yahoo.com - November 25 at 9:13 AM
Surface Oncologys lead cancer programs to advance to combination and expansion stages of early-stage studiesSurface Oncology's lead cancer programs to advance to combination and expansion stages of early-stage studies
seekingalpha.com - November 13 at 1:18 PM
Surface Oncology Announces SRF617 and SRF388 Will Advance to Combination and Expansion Stages of Ongoing Phase 1 Clinical TrialsSurface Oncology Announces SRF617 and SRF388 Will Advance to Combination and Expansion Stages of Ongoing Phase 1 Clinical Trials
finance.yahoo.com - November 13 at 8:04 AM
Surface Oncology shares rise 13% on Fast Track tag for SRF388Surface Oncology shares rise 13% on Fast Track tag for SRF388
seekingalpha.com - November 11 at 8:57 AM
Surface Oncology Announces FDA Fast Track Designation Granted by U.S. Food and Drug Administration for SRF388 to Treat Liver CancerSurface Oncology Announces FDA Fast Track Designation Granted by U.S. Food and Drug Administration for SRF388 to Treat Liver Cancer
finance.yahoo.com - November 11 at 8:56 AM
Surface Oncology Reports Financial Results and Corporate Highlights for Third Quarter 2020Surface Oncology Reports Financial Results and Corporate Highlights for Third Quarter 2020
finance.yahoo.com - November 10 at 9:46 AM
Surface Oncology to Present at the Cowen IO Next SummitSurface Oncology to Present at the Cowen IO Next Summit
finance.yahoo.com - November 9 at 7:21 PM
Surface Oncology to Present SRF388 and SRF114 Preclinical Data at the Upcoming Society for Immunotherapy for Cancer 2020 Virtual ConferenceSurface Oncology to Present SRF388 and SRF114 Preclinical Data at the Upcoming Society for Immunotherapy for Cancer 2020 Virtual Conference
finance.yahoo.com - November 9 at 9:21 AM
Surface Oncology to Report SRF388 Preclinical Data at the Upcoming International Cytokine and Interferon Societys Cytokines 2020 Virtual ConferenceSurface Oncology to Report SRF388 Preclinical Data at the Upcoming International Cytokine and Interferon Society's Cytokines 2020 Virtual Conference
benzinga.com - October 27 at 7:31 AM
Surface Oncology to Report SRF388 Preclinical Data at the Upcoming International Cytokine and Interferon Society’s Cytokines 2020 Virtual ConferenceSurface Oncology to Report SRF388 Preclinical Data at the Upcoming International Cytokine and Interferon Society’s Cytokines 2020 Virtual Conference
finance.yahoo.com - October 26 at 7:37 PM
Is Surface Oncology (NASDAQ:SURF) Using Too Much Debt?Is Surface Oncology (NASDAQ:SURF) Using Too Much Debt?
finance.yahoo.com - October 20 at 4:54 PM
Surface Oncology hires bankers to explore sale - StreetInsiderSurface Oncology hires bankers to explore sale - StreetInsider
seekingalpha.com - October 12 at 2:51 PM
Surface Oncology to Participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech SummitSurface Oncology to Participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
finance.yahoo.com - September 16 at 9:00 PM
Surface Oncology's Shares March Higher, Can It Continue?Surface Oncology's Shares March Higher, Can It Continue?
finance.yahoo.com - September 15 at 12:29 PM
Surface Oncology to Participate in the H.C. Wainwright Global Healthcare ConferenceSurface Oncology to Participate in the H.C. Wainwright Global Healthcare Conference
finance.yahoo.com - September 11 at 3:39 PM
Surface Oncology to Present at the Baird Global Healthcare ConferenceSurface Oncology to Present at the Baird Global Healthcare Conference
finance.yahoo.com - September 9 at 6:04 PM
5 Nucleotidase Market Global Potential Growth, Share, Demand and Analysis of Top Key Players, Research Forecasts to 20265 Nucleotidase Market Global Potential Growth, Share, Demand and Analysis of Top Key Players, Research Forecasts to 2026
marketwatch.com - September 9 at 1:04 PM
PMV Pharma Appoints Laurie Stelzer to the Board of Directors and Robert Ticktin as General CounselPMV Pharma Appoints Laurie Stelzer to the Board of Directors and Robert Ticktin as General Counsel
marketwatch.com - September 8 at 3:01 PM
5 Stocks to Buy as Analysts Initiate Coverage5 Stocks to Buy as Analysts Initiate Coverage
nasdaq.com - September 3 at 1:49 PM
Obsidian Therapeutics Appoints Rob Ross, M.D., to Board of DirectorsObsidian Therapeutics Appoints Rob Ross, M.D., to Board of Directors
prnewswire.com - September 3 at 8:48 AM
Surface Oncology (SURF) Looks Good: Stock Adds 9.8% in SessionSurface Oncology (SURF) Looks Good: Stock Adds 9.8% in Session
finance.yahoo.com - September 2 at 12:46 PM
Surface Oncology +5.8% as Wedbush sees 126% upsideSurface Oncology +5.8% as Wedbush sees 126% upside
seekingalpha.com - August 28 at 2:05 AM
Routine cleaning and disinfecting leaves no trace of coronavirus on surfaces in hospital clinic, study findsRoutine cleaning and disinfecting leaves no trace of coronavirus on surfaces in hospital clinic, study finds
cnbc.com - August 27 at 9:00 PM
What Type Of Shareholders Own The Most Number of Surface Oncology, Inc. (NASDAQ:SURF) Shares?What Type Of Shareholders Own The Most Number of Surface Oncology, Inc. (NASDAQ:SURF) Shares?
finance.yahoo.com - August 19 at 5:02 PM
Surface Oncology EPS beats by $0.07Surface Oncology EPS beats by $0.07
seekingalpha.com - August 11 at 8:19 AM
This page was last updated on 3/3/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.